ThirtyFiveBio is an early-stage drug discovery company that was established in 2021 by a team of experienced pharmaceutical industry professionals and biotech entrepreneurs. Based in Oxford, UK, the company is founded upon a deep understanding of the biology of GPR35. We are currently engaged in a fully enabled drug discovery program to identify novel small-molecule modulators of GPR35
| Website | http://30fivebio.com |
| Employees | 15 (5 on RocketReach) |
| Industry | Biotechnology Research |
| Keywords | Health Technology, Drug Discovery, Biomedical Research, Biotechnology, Pharmaceutical, Therapeutics, Early Stage, Drug Development, Life Sciences, Biopharma, Clinical Trials, Precision Medicine, Biotech Startups, Innovative Therapies, Medicinal Chemistry, Molecular Biology, Pharmaceutical Research, Drug Candidates, Research And Development, New Drugs |
| Competitors | Amgen, Biogen, Genentech, Regeneron, Roche, Gilead Sciences, Novartis, AstraZeneca, Bristol Myers Squibb, Lilly India +49 more (view full list) |
Looking for a particular ThirtyFiveBio employee's phone or email?
ThirtyFiveBio Questions
James Westcott is the CEO of ThirtyFiveBio.
5 people are employed at ThirtyFiveBio.
Top ThirtyFiveBio Employees
-
James Westcott
CEO at ThirtyFiveBio
Oxford, GB1 -
Josselin Caradec
Head of Biology at ThirtyFiveBio
Barcelona, CT, ES42 -
2
Related Companies
G2Crowd Trusted
300K+
Plugin Users
